The global Cyclospora Diagnostic Testing market size was valued at US$ 156.8 million in 2024 and is projected to reach US$ 238.4 million by 2030, at a CAGR of 7.2% during the forecast period 2024-2030.
The United States Cyclospora Diagnostic Testing market size was valued at US$ 52.3 million in 2024 and is projected to reach US$ 76.9 million by 2030, at a CAGR of 6.6% during the forecast period 2024-2030.
Cyclospora Diagnostic Testing involves laboratory procedures and methods used to detect and diagnose Cyclospora cayetanensis infections, a parasitic illness that causes watery diarrhea and other gastrointestinal symptoms.
The global Cyclospora Diagnostic Testing market is experiencing moderate growth, driven by increasing incidence of foodborne illnesses, growing international travel and trade, and improving healthcare infrastructure in developing regions. In 2023, global Cyclospora tests performed reached approximately 2.5 million, with North America accounting for 45% of test volume. PCR-based molecular tests remain the most widely used method, representing 55% of tests, followed by microscopy at 30% and immunoassays at 15%. The market saw a boost from several large-scale Cyclospora outbreaks linked to imported produce, leading to a 20% increase in testing volumes in affected regions in 2023. Technological advancements have focused on improving test sensitivity and turnaround time, with new multiplex PCR assays offering up to 98% sensitivity and results in under 4 hours, compared to 24-48 hours for traditional methods. The market is witnessing strong growth in point-of-care Cyclospora tests, increasing at 15% annually, driven by the need for rapid diagnosis in travel medicine and outbreak scenarios. In 2023, new FDA guidelines for testing imported produce led to a 25% increase in preventive Cyclospora testing in the food industry. The industry faces challenges from the seasonal nature of Cyclospora infections and limited awareness in some regions, but increasing globalization of food supply chains continues to drive demand for robust testing methods. Emerging applications in environmental monitoring are showing promise, with Cyclospora testing for water sources and agricultural runoff growing at 18% CAGR, albeit from a small base of 2% market share. Looking ahead, the market is expected to benefit from advancements in genomic epidemiology, with next-generation sequencing-based Cyclospora typing methods for outbreak investigations projected to grow at 22% CAGR through 2030.
Report Overview
Cyclospora cayetanensis, a single-celled coccidian parasitic pathogen, causes intestinal infection resulting in diarrhea. In medical terminology, this diarrheal infection is referred as cyclospora infection (cyclosporiasis).
This report provides a deep insight into the global Cyclospora Diagnostic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cyclospora Diagnostic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cyclospora Diagnostic Testing market in any manner.
Global Cyclospora Diagnostic Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Thermo Fisher Scientific
Beckman Coulter, Inc
bioMerieux, Inc.
CEPHEID
Diamedix Corporation
Hologic, Inc
Nanogen, Inc.
Ortho Clinical Diagnostics (a Johnson & Johnson company)
DiaSorin S.p.A.
Roche Diagnostics (a division of Hoffmann-La Roche)
Siemens Healthcare
QIAGEN N.V.
Wako Chemicals USA, Inc.
Market Segmentation (by Type)
Acid-fast Staining
Safranin Staining
Market Segmentation (by Application)
Commercial or Private Laboratories
Hospitals
Public Health Labs
Physician Offices
Geographic Segmentation
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cyclospora Diagnostic Testing
1.2 Key Market Segments
1.2.1 Cyclospora Diagnostic Testing Segment by Type
1.2.2 Cyclospora Diagnostic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cyclospora Diagnostic Testing Market Overview
2.1 Global Market Overview
2.1.1 Global Cyclospora Diagnostic Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cyclospora Diagnostic Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cyclospora Diagnostic Testing Market Competitive Landscape
3.1 Global Cyclospora Diagnostic Testing Sales by Manufacturers (2019-2024)
3.2 Global Cyclospora Diagnostic Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Cyclospora Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cyclospora Diagnostic Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cyclospora Diagnostic Testing Sales Sites, Area Served, Product Type
3.6 Cyclospora Diagnostic Testing Market Competitive Situation and Trends
3.6.1 Cyclospora Diagnostic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cyclospora Diagnostic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cyclospora Diagnostic Testing Industry Chain Analysis
4.1 Cyclospora Diagnostic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cyclospora Diagnostic Testing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cyclospora Diagnostic Testing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cyclospora Diagnostic Testing Sales Market Share by Type (2019-2024)
6.3 Global Cyclospora Diagnostic Testing Market Size Market Share by Type (2019-2024)
6.4 Global Cyclospora Diagnostic Testing Price by Type (2019-2024)
7 Cyclospora Diagnostic Testing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cyclospora Diagnostic Testing Market Sales by Application (2019-2024)
7.3 Global Cyclospora Diagnostic Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Cyclospora Diagnostic Testing Sales Growth Rate by Application (2019-2024)
8 Cyclospora Diagnostic Testing Market Segmentation by Region
8.1 Global Cyclospora Diagnostic Testing Sales by Region
8.1.1 Global Cyclospora Diagnostic Testing Sales by Region
8.1.2 Global Cyclospora Diagnostic Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Cyclospora Diagnostic Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cyclospora Diagnostic Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cyclospora Diagnostic Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cyclospora Diagnostic Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cyclospora Diagnostic Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Cyclospora Diagnostic Testing Basic Information
9.1.2 Thermo Fisher Scientific Cyclospora Diagnostic Testing Product Overview
9.1.3 Thermo Fisher Scientific Cyclospora Diagnostic Testing Product Market Performance
9.1.4 Thermo Fisher Scientific Business Overview
9.1.5 Thermo Fisher Scientific Cyclospora Diagnostic Testing SWOT Analysis
9.1.6 Thermo Fisher Scientific Recent Developments
9.2 Beckman Coulter, Inc
9.2.1 Beckman Coulter, Inc Cyclospora Diagnostic Testing Basic Information
9.2.2 Beckman Coulter, Inc Cyclospora Diagnostic Testing Product Overview
9.2.3 Beckman Coulter, Inc Cyclospora Diagnostic Testing Product Market Performance
9.2.4 Beckman Coulter, Inc Business Overview
9.2.5 Beckman Coulter, Inc Cyclospora Diagnostic Testing SWOT Analysis
9.2.6 Beckman Coulter, Inc Recent Developments
9.3 bioMerieux, Inc.
9.3.1 bioMerieux, Inc. Cyclospora Diagnostic Testing Basic Information
9.3.2 bioMerieux, Inc. Cyclospora Diagnostic Testing Product Overview
9.3.3 bioMerieux, Inc. Cyclospora Diagnostic Testing Product Market Performance
9.3.4 bioMerieux, Inc. Cyclospora Diagnostic Testing SWOT Analysis
9.3.5 bioMerieux, Inc. Business Overview
9.3.6 bioMerieux, Inc. Recent Developments
9.4 CEPHEID
9.4.1 CEPHEID Cyclospora Diagnostic Testing Basic Information
9.4.2 CEPHEID Cyclospora Diagnostic Testing Product Overview
9.4.3 CEPHEID Cyclospora Diagnostic Testing Product Market Performance
9.4.4 CEPHEID Business Overview
9.4.5 CEPHEID Recent Developments
9.5 Diamedix Corporation
9.5.1 Diamedix Corporation Cyclospora Diagnostic Testing Basic Information
9.5.2 Diamedix Corporation Cyclospora Diagnostic Testing Product Overview
9.5.3 Diamedix Corporation Cyclospora Diagnostic Testing Product Market Performance
9.5.4 Diamedix Corporation Business Overview
9.5.5 Diamedix Corporation Recent Developments
9.6 Hologic, Inc
9.6.1 Hologic, Inc Cyclospora Diagnostic Testing Basic Information
9.6.2 Hologic, Inc Cyclospora Diagnostic Testing Product Overview
9.6.3 Hologic, Inc Cyclospora Diagnostic Testing Product Market Performance
9.6.4 Hologic, Inc Business Overview
9.6.5 Hologic, Inc Recent Developments
9.7 Nanogen, Inc.
9.7.1 Nanogen, Inc. Cyclospora Diagnostic Testing Basic Information
9.7.2 Nanogen, Inc. Cyclospora Diagnostic Testing Product Overview
9.7.3 Nanogen, Inc. Cyclospora Diagnostic Testing Product Market Performance
9.7.4 Nanogen, Inc. Business Overview
9.7.5 Nanogen, Inc. Recent Developments
9.8 Ortho Clinical Diagnostics (a Johnson and Johnson company)
9.8.1 Ortho Clinical Diagnostics (a Johnson and Johnson company) Cyclospora Diagnostic Testing Basic Information
9.8.2 Ortho Clinical Diagnostics (a Johnson and Johnson company) Cyclospora Diagnostic Testing Product Overview
9.8.3 Ortho Clinical Diagnostics (a Johnson and Johnson company) Cyclospora Diagnostic Testing Product Market Performance
9.8.4 Ortho Clinical Diagnostics (a Johnson and Johnson company) Business Overview
9.8.5 Ortho Clinical Diagnostics (a Johnson and Johnson company) Recent Developments
9.9 DiaSorin S.p.A.
9.9.1 DiaSorin S.p.A. Cyclospora Diagnostic Testing Basic Information
9.9.2 DiaSorin S.p.A. Cyclospora Diagnostic Testing Product Overview
9.9.3 DiaSorin S.p.A. Cyclospora Diagnostic Testing Product Market Performance
9.9.4 DiaSorin S.p.A. Business Overview
9.9.5 DiaSorin S.p.A. Recent Developments
9.10 Roche Diagnostics (a division of Hoffmann-La Roche)
9.10.1 Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Basic Information
9.10.2 Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Product Overview
9.10.3 Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Product Market Performance
9.10.4 Roche Diagnostics (a division of Hoffmann-La Roche) Business Overview
9.10.5 Roche Diagnostics (a division of Hoffmann-La Roche) Recent Developments
9.11 Siemens Healthcare
9.11.1 Siemens Healthcare Cyclospora Diagnostic Testing Basic Information
9.11.2 Siemens Healthcare Cyclospora Diagnostic Testing Product Overview
9.11.3 Siemens Healthcare Cyclospora Diagnostic Testing Product Market Performance
9.11.4 Siemens Healthcare Business Overview
9.11.5 Siemens Healthcare Recent Developments
9.12 QIAGEN N.V.
9.12.1 QIAGEN N.V. Cyclospora Diagnostic Testing Basic Information
9.12.2 QIAGEN N.V. Cyclospora Diagnostic Testing Product Overview
9.12.3 QIAGEN N.V. Cyclospora Diagnostic Testing Product Market Performance
9.12.4 QIAGEN N.V. Business Overview
9.12.5 QIAGEN N.V. Recent Developments
9.13 Wako Chemicals USA, Inc.
9.13.1 Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Basic Information
9.13.2 Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Product Overview
9.13.3 Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Product Market Performance
9.13.4 Wako Chemicals USA, Inc. Business Overview
9.13.5 Wako Chemicals USA, Inc. Recent Developments
10 Cyclospora Diagnostic Testing Market Forecast by Region
10.1 Global Cyclospora Diagnostic Testing Market Size Forecast
10.2 Global Cyclospora Diagnostic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cyclospora Diagnostic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Cyclospora Diagnostic Testing Market Size Forecast by Region
10.2.4 South America Cyclospora Diagnostic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cyclospora Diagnostic Testing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cyclospora Diagnostic Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cyclospora Diagnostic Testing by Type (2025-2030)
11.1.2 Global Cyclospora Diagnostic Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cyclospora Diagnostic Testing by Type (2025-2030)
11.2 Global Cyclospora Diagnostic Testing Market Forecast by Application (2025-2030)
11.2.1 Global Cyclospora Diagnostic Testing Sales (K Units) Forecast by Application
11.2.2 Global Cyclospora Diagnostic Testing Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cyclospora Diagnostic Testing Market Size Comparison by Region (M USD)
Table 5. Global Cyclospora Diagnostic Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cyclospora Diagnostic Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cyclospora Diagnostic Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cyclospora Diagnostic Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclospora Diagnostic Testing as of 2022)
Table 10. Global Market Cyclospora Diagnostic Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cyclospora Diagnostic Testing Sales Sites and Area Served
Table 12. Manufacturers Cyclospora Diagnostic Testing Product Type
Table 13. Global Cyclospora Diagnostic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cyclospora Diagnostic Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cyclospora Diagnostic Testing Market Challenges
Table 22. Global Cyclospora Diagnostic Testing Sales by Type (K Units)
Table 23. Global Cyclospora Diagnostic Testing Market Size by Type (M USD)
Table 24. Global Cyclospora Diagnostic Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Cyclospora Diagnostic Testing Sales Market Share by Type (2019-2024)
Table 26. Global Cyclospora Diagnostic Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Cyclospora Diagnostic Testing Market Size Share by Type (2019-2024)
Table 28. Global Cyclospora Diagnostic Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cyclospora Diagnostic Testing Sales (K Units) by Application
Table 30. Global Cyclospora Diagnostic Testing Market Size by Application
Table 31. Global Cyclospora Diagnostic Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Cyclospora Diagnostic Testing Sales Market Share by Application (2019-2024)
Table 33. Global Cyclospora Diagnostic Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Cyclospora Diagnostic Testing Market Share by Application (2019-2024)
Table 35. Global Cyclospora Diagnostic Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Cyclospora Diagnostic Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Cyclospora Diagnostic Testing Sales Market Share by Region (2019-2024)
Table 38. North America Cyclospora Diagnostic Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cyclospora Diagnostic Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cyclospora Diagnostic Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Cyclospora Diagnostic Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cyclospora Diagnostic Testing Sales by Region (2019-2024) & (K Units)
Table 43. Thermo Fisher Scientific Cyclospora Diagnostic Testing Basic Information
Table 44. Thermo Fisher Scientific Cyclospora Diagnostic Testing Product Overview
Table 45. Thermo Fisher Scientific Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Cyclospora Diagnostic Testing SWOT Analysis
Table 48. Thermo Fisher Scientific Recent Developments
Table 49. Beckman Coulter, Inc Cyclospora Diagnostic Testing Basic Information
Table 50. Beckman Coulter, Inc Cyclospora Diagnostic Testing Product Overview
Table 51. Beckman Coulter, Inc Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Beckman Coulter, Inc Business Overview
Table 53. Beckman Coulter, Inc Cyclospora Diagnostic Testing SWOT Analysis
Table 54. Beckman Coulter, Inc Recent Developments
Table 55. bioMerieux, Inc. Cyclospora Diagnostic Testing Basic Information
Table 56. bioMerieux, Inc. Cyclospora Diagnostic Testing Product Overview
Table 57. bioMerieux, Inc. Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. bioMerieux, Inc. Cyclospora Diagnostic Testing SWOT Analysis
Table 59. bioMerieux, Inc. Business Overview
Table 60. bioMerieux, Inc. Recent Developments
Table 61. CEPHEID Cyclospora Diagnostic Testing Basic Information
Table 62. CEPHEID Cyclospora Diagnostic Testing Product Overview
Table 63. CEPHEID Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. CEPHEID Business Overview
Table 65. CEPHEID Recent Developments
Table 66. Diamedix Corporation Cyclospora Diagnostic Testing Basic Information
Table 67. Diamedix Corporation Cyclospora Diagnostic Testing Product Overview
Table 68. Diamedix Corporation Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Diamedix Corporation Business Overview
Table 70. Diamedix Corporation Recent Developments
Table 71. Hologic, Inc Cyclospora Diagnostic Testing Basic Information
Table 72. Hologic, Inc Cyclospora Diagnostic Testing Product Overview
Table 73. Hologic, Inc Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Hologic, Inc Business Overview
Table 75. Hologic, Inc Recent Developments
Table 76. Nanogen, Inc. Cyclospora Diagnostic Testing Basic Information
Table 77. Nanogen, Inc. Cyclospora Diagnostic Testing Product Overview
Table 78. Nanogen, Inc. Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Nanogen, Inc. Business Overview
Table 80. Nanogen, Inc. Recent Developments
Table 81. Ortho Clinical Diagnostics (a Johnson and Johnson company) Cyclospora Diagnostic Testing Basic Information
Table 82. Ortho Clinical Diagnostics (a Johnson and Johnson company) Cyclospora Diagnostic Testing Product Overview
Table 83. Ortho Clinical Diagnostics (a Johnson and Johnson company) Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Ortho Clinical Diagnostics (a Johnson and Johnson company) Business Overview
Table 85. Ortho Clinical Diagnostics (a Johnson and Johnson company) Recent Developments
Table 86. DiaSorin S.p.A. Cyclospora Diagnostic Testing Basic Information
Table 87. DiaSorin S.p.A. Cyclospora Diagnostic Testing Product Overview
Table 88. DiaSorin S.p.A. Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. DiaSorin S.p.A. Business Overview
Table 90. DiaSorin S.p.A. Recent Developments
Table 91. Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Basic Information
Table 92. Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Product Overview
Table 93. Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Roche Diagnostics (a division of Hoffmann-La Roche) Business Overview
Table 95. Roche Diagnostics (a division of Hoffmann-La Roche) Recent Developments
Table 96. Siemens Healthcare Cyclospora Diagnostic Testing Basic Information
Table 97. Siemens Healthcare Cyclospora Diagnostic Testing Product Overview
Table 98. Siemens Healthcare Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Siemens Healthcare Business Overview
Table 100. Siemens Healthcare Recent Developments
Table 101. QIAGEN N.V. Cyclospora Diagnostic Testing Basic Information
Table 102. QIAGEN N.V. Cyclospora Diagnostic Testing Product Overview
Table 103. QIAGEN N.V. Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. QIAGEN N.V. Business Overview
Table 105. QIAGEN N.V. Recent Developments
Table 106. Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Basic Information
Table 107. Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Product Overview
Table 108. Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Wako Chemicals USA, Inc. Business Overview
Table 110. Wako Chemicals USA, Inc. Recent Developments
Table 111. Global Cyclospora Diagnostic Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Cyclospora Diagnostic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Cyclospora Diagnostic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Cyclospora Diagnostic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Cyclospora Diagnostic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Cyclospora Diagnostic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Cyclospora Diagnostic Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Cyclospora Diagnostic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Cyclospora Diagnostic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Cyclospora Diagnostic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Cyclospora Diagnostic Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Cyclospora Diagnostic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Cyclospora Diagnostic Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Cyclospora Diagnostic Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Cyclospora Diagnostic Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Cyclospora Diagnostic Testing Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Cyclospora Diagnostic Testing Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Cyclospora Diagnostic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cyclospora Diagnostic Testing Market Size (M USD), 2019-2030
Figure 5. Global Cyclospora Diagnostic Testing Market Size (M USD) (2019-2030)
Figure 6. Global Cyclospora Diagnostic Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cyclospora Diagnostic Testing Market Size by Country (M USD)
Figure 11. Cyclospora Diagnostic Testing Sales Share by Manufacturers in 2023
Figure 12. Global Cyclospora Diagnostic Testing Revenue Share by Manufacturers in 2023
Figure 13. Cyclospora Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cyclospora Diagnostic Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cyclospora Diagnostic Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cyclospora Diagnostic Testing Market Share by Type
Figure 18. Sales Market Share of Cyclospora Diagnostic Testing by Type (2019-2024)
Figure 19. Sales Market Share of Cyclospora Diagnostic Testing by Type in 2023
Figure 20. Market Size Share of Cyclospora Diagnostic Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Cyclospora Diagnostic Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cyclospora Diagnostic Testing Market Share by Application
Figure 24. Global Cyclospora Diagnostic Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Cyclospora Diagnostic Testing Sales Market Share by Application in 2023
Figure 26. Global Cyclospora Diagnostic Testing Market Share by Application (2019-2024)
Figure 27. Global Cyclospora Diagnostic Testing Market Share by Application in 2023
Figure 28. Global Cyclospora Diagnostic Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cyclospora Diagnostic Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cyclospora Diagnostic Testing Sales Market Share by Country in 2023
Figure 32. U.S. Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cyclospora Diagnostic Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cyclospora Diagnostic Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cyclospora Diagnostic Testing Sales Market Share by Country in 2023
Figure 37. Germany Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cyclospora Diagnostic Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cyclospora Diagnostic Testing Sales Market Share by Region in 2023
Figure 44. China Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cyclospora Diagnostic Testing Sales and Growth Rate (K Units)
Figure 50. South America Cyclospora Diagnostic Testing Sales Market Share by Country in 2023
Figure 51. Brazil Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cyclospora Diagnostic Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cyclospora Diagnostic Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cyclospora Diagnostic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cyclospora Diagnostic Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cyclospora Diagnostic Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cyclospora Diagnostic Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cyclospora Diagnostic Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Cyclospora Diagnostic Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Cyclospora Diagnostic Testing Market Share Forecast by Application (2025-2030)
